SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Alkem Laboratories board to consider second interim dividend

02 Mar 2016 Evaluate

Alkem Laboratories has informed that a meeting of the Board of Directors of the Company will be held on March 09, 2016, to consider and approve second interim dividend for the Financial Year 2015-16. Further in terms of the Alkem Laboratories - Code of Conduct for Regulating, Monitoring and Reporting of Trading by Insiders, the Trading Window for dealing in the securities of the Company shall remain closed from March 02, 2016 to the closure of business hours of March 11, 2016.

The above information is a part of company’s filings submitted to BSE.  

Alkem Laboratories Share Price

5516.60 -88.60 (-1.58%)
23-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1679.85
Dr. Reddys Lab 1333.05
Cipla 1305.85
Zydus Lifesciences 947.10
Lupin 2340.20
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×